APTNOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ADAPTIN BIO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.27+0.00 (0.00%)
Close on Aug 19, 2026
- Market cap
- $55.48M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.67 (+11.96%)since May 14, 2026
Weekly closes, adjusted for splits, on a log scale. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $55.48M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$5.40M
- EPS, diluted
- -$0.66
- Book value per share
- -$0.19
- Diluted shares
- 9M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Operating income
-$5.39M
Net income
-$5.40M
EPS, diluted
–
Reported periodTrailing twelve months